Research output per year
Research output per year
Personal profile
Research interests
My research focuses on the (cost-)effectiveness of colorectal cancer (CRC) screening. Using the ASCCA model, I evaluate the potential of new biomarker tests in CRC screening and surveillance.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening
Koffijberg, H., Degeling, K., IJzerman, M. J., Coupé, V. M. H. & Greuter, M. J. E., Feb 2021, In: Value in Health. 24, 2, 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening?
Greuter, M. J., Carvalho, B., Wit, M. D., Dekker, E., Spaander, M. C., Meijer, G. A., Engeland, M. V. & Coupé, V. M., 1 Jun 2020, In: Journal of comparative effectiveness research. 9, 8, p. 563-571 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer
van 't Erve, I., Greuter, M. J. E., Bolhuis, K., Vessies, D. C. L., Leal, A., Vink, G. R., van den Broek, D., Velculescu, V. E., Punt, C. J. A., Meijer, G. A., Coupé, V. M. H. & Fijneman, R. J. A., Dec 2020, In: Journal of Molecular Diagnostics. 22, 12, p. 1430-1437 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data
Jongeneel, G., Klausch, T., van Erning, F. N., Vink, G. R., Koopman, M., Punt, C. J. A., Greuter, M. J. E. & Coupé, V. M. H., 1 Jun 2020, In: International Journal of Cancer. 146, 11, p. 2968-2978 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
Jongeneel, G., Greuter, M. J. E., van Erning, F. N., Koopman, M., Vink, G. R., Punt, C. J. A. & Coupé, V. M. H., 2020, In: Therapeutic Advances in Gastroenterology. 13Research output: Contribution to journal › Article › Academic › peer-review
Open Access